In our TMA, patients with detectable levels of PGLYRP1 in the tumour compartment presented lower infiltration of immune cells (online supplemental figure S7H), although not significant, again probably due to the limited number of samples. The gene discussed is PGLYRP1; the disease is neoplasm.